List of Tables
Table 1. Global lmmune Checkpoint Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PD-1
Table 3. Key Players of PD-L1
Table 4. Key Players of CTLA-4
Table 5. Global lmmune Checkpoint Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global lmmune Checkpoint Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global lmmune Checkpoint Inhibitors Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global lmmune Checkpoint Inhibitors Market Share by Region (2020-2025)
Table 9. Global lmmune Checkpoint Inhibitors Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global lmmune Checkpoint Inhibitors Market Share by Region (2026-2031)
Table 11. lmmune Checkpoint Inhibitors Market Trends
Table 12. lmmune Checkpoint Inhibitors Market Drivers
Table 13. lmmune Checkpoint Inhibitors Market Challenges
Table 14. lmmune Checkpoint Inhibitors Market Restraints
Table 15. Global lmmune Checkpoint Inhibitors Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global lmmune Checkpoint Inhibitors Market Share by Players (2020-2025)
Table 17. Global Top lmmune Checkpoint Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in lmmune Checkpoint Inhibitors as of 2024)
Table 18. Ranking of Global Top lmmune Checkpoint Inhibitors Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by lmmune Checkpoint Inhibitors Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of lmmune Checkpoint Inhibitors, Headquarters and Area Served
Table 21. Global Key Players of lmmune Checkpoint Inhibitors, Product and Application
Table 22. Global Key Players of lmmune Checkpoint Inhibitors, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global lmmune Checkpoint Inhibitors Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global lmmune Checkpoint Inhibitors Revenue Market Share by Type (2020-2025)
Table 26. Global lmmune Checkpoint Inhibitors Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global lmmune Checkpoint Inhibitors Revenue Market Share by Type (2026-2031)
Table 28. Global lmmune Checkpoint Inhibitors Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global lmmune Checkpoint Inhibitors Revenue Market Share by Application (2020-2025)
Table 30. Global lmmune Checkpoint Inhibitors Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global lmmune Checkpoint Inhibitors Revenue Market Share by Application (2026-2031)
Table 32. North America lmmune Checkpoint Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America lmmune Checkpoint Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America lmmune Checkpoint Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe lmmune Checkpoint Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe lmmune Checkpoint Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe lmmune Checkpoint Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific lmmune Checkpoint Inhibitors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific lmmune Checkpoint Inhibitors Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific lmmune Checkpoint Inhibitors Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America lmmune Checkpoint Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America lmmune Checkpoint Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America lmmune Checkpoint Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa lmmune Checkpoint Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa lmmune Checkpoint Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa lmmune Checkpoint Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 47. AstraZeneca Company Details
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca lmmune Checkpoint Inhibitors Product
Table 50. AstraZeneca Revenue in lmmune Checkpoint Inhibitors Business (2020-2025) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. Bristol-Myers Squibb Company Details
Table 53. Bristol-Myers Squibb Business Overview
Table 54. Bristol-Myers Squibb lmmune Checkpoint Inhibitors Product
Table 55. Bristol-Myers Squibb Revenue in lmmune Checkpoint Inhibitors Business (2020-2025) & (US$ Million)
Table 56. Bristol-Myers Squibb Recent Development
Table 57. Roche Holdings AG Company Details
Table 58. Roche Holdings AG Business Overview
Table 59. Roche Holdings AG lmmune Checkpoint Inhibitors Product
Table 60. Roche Holdings AG Revenue in lmmune Checkpoint Inhibitors Business (2020-2025) & (US$ Million)
Table 61. Roche Holdings AG Recent Development
Table 62. Novartis AG Company Details
Table 63. Novartis AG Business Overview
Table 64. Novartis AG lmmune Checkpoint Inhibitors Product
Table 65. Novartis AG Revenue in lmmune Checkpoint Inhibitors Business (2020-2025) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer lmmune Checkpoint Inhibitors Product
Table 70. Pfizer Revenue in lmmune Checkpoint Inhibitors Business (2020-2025) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi lmmune Checkpoint Inhibitors Product
Table 75. Sanofi Revenue in lmmune Checkpoint Inhibitors Business (2020-2025) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report
List of Figures
Figure 1. lmmune Checkpoint Inhibitors Picture
Figure 2. Global lmmune Checkpoint Inhibitors Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global lmmune Checkpoint Inhibitors Market Share by Type: 2024 VS 2031
Figure 4. PD-1 Features
Figure 5. PD-L1 Features
Figure 6. CTLA-4 Features
Figure 7. Global lmmune Checkpoint Inhibitors Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global lmmune Checkpoint Inhibitors Market Share by Application: 2024 VS 2031
Figure 9. Lung Cancer Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Others Case Studies
Figure 12. lmmune Checkpoint Inhibitors Report Years Considered
Figure 13. Global lmmune Checkpoint Inhibitors Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global lmmune Checkpoint Inhibitors Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global lmmune Checkpoint Inhibitors Market Share by Region: 2024 VS 2031
Figure 16. Global lmmune Checkpoint Inhibitors Market Share by Players in 2024
Figure 17. Global Top lmmune Checkpoint Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in lmmune Checkpoint Inhibitors as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by lmmune Checkpoint Inhibitors Revenue in 2024
Figure 19. North America lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America lmmune Checkpoint Inhibitors Market Share by Country (2020-2031)
Figure 21. United States lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe lmmune Checkpoint Inhibitors Market Share by Country (2020-2031)
Figure 25. Germany lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific lmmune Checkpoint Inhibitors Market Share by Region (2020-2031)
Figure 33. China lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America lmmune Checkpoint Inhibitors Market Share by Country (2020-2031)
Figure 41. Mexico lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa lmmune Checkpoint Inhibitors Market Share by Country (2020-2031)
Figure 45. Turkey lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE lmmune Checkpoint Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. AstraZeneca Revenue Growth Rate in lmmune Checkpoint Inhibitors Business (2020-2025)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in lmmune Checkpoint Inhibitors Business (2020-2025)
Figure 50. Roche Holdings AG Revenue Growth Rate in lmmune Checkpoint Inhibitors Business (2020-2025)
Figure 51. Novartis AG Revenue Growth Rate in lmmune Checkpoint Inhibitors Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in lmmune Checkpoint Inhibitors Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in lmmune Checkpoint Inhibitors Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
